866-997-4948(US-Canada Toll Free)

Japan In Vitro Diagnostics (IVD) Market, by Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities

Published By :

Renub Research

Published Date : Oct 2018

Category :

In Vitro Diagnostics

No. of Pages : 139 Pages

In Japan In Vitro Diagnostic comes under medical device, which is consumable or disposable and used to collect numerous bio-samples under various medical conditions. According to Renub Research Japan In Vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024.

Ageing Population will Foster the Growth of Japan In Vitro Diagnostics Market

Japan has highest proportion of ageing population globally; almost its quarter of population is 65+ age. Rise in number of ageing population is the biggest burden for Japanese government because prevalence of ageing disease rising at rapid pace. So Japanese government has given priority to deal with ageing population and it is expected that government will allocate skyrocket healthcare budget in 2025 for ageing. Therefore rising prevalence and increased public expenditure will boost the Japan In Vitro Diagnostics Market in future.

Pathology Market is the Fastest Growing Segment in Japan In Vitro Diagnostics Market

In this report Renub Research has done in-depth study of 11 segments of Japan In-vitro Diagnostic Market: Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing and Others. The report gives you comprehensive insight of each segment of In-vitro diagnostic along with separate growth factors for each of segments.

Positive Reimbursement Policy will further boost the Market of Japan In Vitro Diagnostics Market

This report by Renub Research explains length and breadth of reimbursement policies along with complete framework. It also provides clear insight & structure of how it works actually, how to take approval from Japanese authorities regarding reimbursement policies. It explains classification of medical devices in Japan and which class In vitro diagnostic fits. It covers all medical manufacturer applied for reimbursement approval in Japan for past five years.

Continuous Advancement of Diagnostic Technology & non-invasive Technique will improve the Growth of Japan In Vitro Diagnostics Market

The advancement in In vitro Diagnostic technique has made it simpler to diagnose with lesser time being less invasive. The improved digitization in pathology has gain the ability to deliver the clinical outcome within the stipulated time-frame. Japan has successfully done the trial for first urine test to diagnose cancer in the world in 2018. Moreover for colon cancer, screening is conducted via a feces test. All these technology improvement will further enhance the Japan In vitro Diagnostic market.

In this report, we have covered the most important section Market Dynamic, which explains various factors responsible for future growth, challenges and opportunities for Japan In vitro Diagnostics.

Porter's Five Forces Analysis

In this report, we provide in-depth analysis of all five forces and their significant impact on market supply and demand of Japan In-vitro Diagnostic products. 

Renub Research report titled “Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Biomerieux, Abbott Laboratories & Danaher Corporation), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities” provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market. 

By Segment

  • Urine & Feces
  • Hematology
  • Clinical Chemistry
  • Self Monitoring of Blood Glucose (SMBG)
  • Tumor Marker
  • Immunology
  • Infectious disease
  • Microbiology
  • Pathology
  • Genetic Testing
  • Others

Company Analysis

  • Roche Diagnostics 
  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux      

Table of Content

1. Introduction   
1.1 Market Definition 
1.2 Currency Conversion 

2. Research Methodology 

3. Executive Summary 

4. Market Outlook - Japan In-vitro Diagnostics Market 

5. Market Share Analysis 

6. By Segments - Japan In-vitro Diagnostics Market  
6.1 Urine & Faces Diagnostics 
6.2 Hematology 
6.3 Clinical Chemistry 
6.4 Self-Blood Glucose Monitoring 
6.5 Tumor Marker 
6.6 Immunology 
6.7 Infectious Testing 
6.8 Microbiology 
6.9 Pathology 
6.10 Genetic Testing 
6.11 Others   

7. Porter's Five Forces Analysis 
7.1 Threat of New Entry 
7.2 The Bargaining Power of Buyer 
7.3 Threat of Substitution 
7.4 The Bargaining Power of Supplier 
7.5 Competitive Rivalry 

8. Market Dynamics 
8.1 Growth Drivers 
8.2 Challenges 
8.3 Opportunities 

9. Reimbursement Policy 

10. Abbott Laboratories - Company Analysis   
10.1 Company Overview  
10.2 Company Initiatives  
10.2.1 Point 1 
10.2.2 Point 2
10.2.3 Point 3
10.3 Financial Insight  

11. Danaher Corporation - Company Analysis 
11.1 Company Overview 
11.2 Company Initiatives 
11.2.1 Point 1
11.2.2 Point 2
11.3 Financial Insight 

12. Biomerieux  – Company Analysis 
12.1 Company Overview 
12.2 Company Initiatives 
12.2.1 Point 1
12.2.2 Point 2
12.2.3 Point 3
12.3 Financial Insight 

13. Roche Diagnostics – Company Analysis 
13.1 Company Overview 
13.2 Company Initiatives 
13.2.1 Point 1
13.2.2 Point 2
13.3 Financial Insight 

List of Table

Table-1: Japan – In-vitro Diagnostics Market Share (Percent), 2008 – 2017
Table-2: Japan – Forecast for In-vitro Diagnostics Market Share (Percent), 2018 – 2024
Table-3: Japan– Medical Device Classification
Table-4: New reimbursement evaluated between October 31, 2012, to November 22, 2017

List of Chart

Figure-1: Japan– In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure-2: Japan– In-vitro Diagnostic Top Two Rapid Growing Segment
Figure-3: Japan– In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2017 & 2024
Figure-4: Japan– In-vitro Diagnostics Market (Million US$), 2008 – 2017
Figure-5: Japan– Forecast for In-vitro Diagnostics Market (Million US$), 2018 – 2024
Figure-6: Japan– Urine & Faces Diagnostics Market (Million US$), 2008 – 2017
Figure-7: Japan– Forecast for Urine & Faces Diagnostics Market (Million US$), 2018 – 2024
Figure-8: Japan– Hematology Market (Million US$), 2008 – 2017
Figure-9: Japan– Forecast for Hematology Market (Million US$), 2018 – 2024
Figure-10: Japan– Clinical Chemistry Market (Million US$), 2008 – 2017
Figure-11: Japan– Forecast for Clinical Chemistry Market (Million US$), 2018 – 2024
Figure-12: Japan– SMBG  Market (Million US$), 2008 – 2017
Figure-13: Japan– Forecast for SMBG Market (Million US$), 2018 – 2024
Figure-14: Japan– Tumor Marker Market (Million US$), 2008 – 2017
Figure-15: Japan– Forecast for Tumor Marker Market (Million US$), 2018 – 2024
Figure-16: Japan– Immunology  Market (Million US$), 2008 – 2017
Figure-17: Japan– Forecast for Immunology Market (Million US$), 2018 – 2024
Figure-18: Japan– Infectious Disease Market (Million US$), 2008 – 2017
Figure-19: Japan– Forecast for Infectious Disease Market (Million US$), 2018 – 2024
Figure-20: Japan– Microbiology Testing Market (Million US$), 2008 – 2017
Figure-21: Japan– Forecast for Microbiology Testing Market (Million US$), 2018 – 2024
Figure-21: Japan– Pathology Market (Million US$), 2008 – 2017
Figure-22: Japan– Forecast for Pathology Market (Million US$), 2018 – 2024
Figure-23: Japan– Genetic Testing Market (Million US$), 2008 – 2017
Figure-24: Japan– Forecast for Genetic Testing Market (Million US$), 2018 – 2024
Figure-25: Japan– Others Market (Million US$), 2008 – 2017
Figure-26: Japan– Forecast for Others Market (Million US$), 2018 – 2024
Figure-27: Abbott Laboratories – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure-28: Abbott Laboratories – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure-29: Danaher Corporation – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure-30: Danaher Corporation – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure-31: Biomerieux – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure-32: Biomerieux – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure-33: Roche Diagnostics – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure-34: Roche Diagnostics – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *